Thursday, May 12, 2016

This just in...

The FDA is making changes regarding the prescribing of fluoroquinolone antibiotics!!! It's too late for me but it should save others from this nightmare. I just read the following;
"As you may know, the Quinolone Vigilance Foundation testified at the Food and Drug Administration regarding the use of fluoroquinolones. Thirty-five patients and patient advocates joined together to speak in front of an advisory panel.
The FDA listened. Just moments ago, Executive Director Rachel Brummert received the following:
"Today, the FDA is requiring label changes for antibacterial drugs called fluoroquinolones, including an updated boxed warning and Medication Guide, and advising that the serious side effects associated with fluoroquinolones generally outweigh the benefits for patients with sinusitis, bronchitis and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolones should be reserved for those who do not have alternative treatment options.
An FDA safety review has shown that fluoroquinolones are associated with disabling and potentially permanent, serious side effects that can occur together. These side effects can involve the tendons, muscles, joints, nerves and central nervous system. As a result, the FDA is requiring label changes for all systemic fluoroquinolone antibacterial drugs to reflect this new safety information."
Thank you to everyone who submitted public comments and who traveled to the advisory hearing to share their stories!"
I was one of those who traveled to the FDA hearing last November and I submitted my story to the advisory board beforehand.

This is the link to the official announcement;  http://www.fda.gov/downloads/Drugs/DrugSafety/UCM500591.pdf

And if that isn't enough the image below was taken from a CDC article and here is the link; http://www.cdc.gov/getsmart/community/about/should-know.html

2 comments:

  1. Here's the FDA announcement;
    http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm500325.htm

    ReplyDelete
  2. And the FDA communication;
    http://www.fda.gov/downloads/Drugs/DrugSafety/UCM500591.pdf

    ReplyDelete